IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
CRISPR/CAS9-Mediated Genome Editing of miRNA-155 Inhibits Proinflammatory Cytokine Production by RAW264.7 Cells
Jing, Weixia1; Zhang, Xuewu2; Sun, Wenyan3; Hou, Xiujuan4; Yao, Zhongqiang5; Zhu, Yuelan4
刊名BIOMED RESEARCH INTERNATIONAL
2015
DOI10.1155/2015/326042
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Biotechnology & Applied Microbiology ; Medicine, Research & Experimental
资助者National Natural Science Foundation of China ; National Natural Science Foundation of China
研究领域[WOS]Biotechnology & Applied Microbiology ; Research & Experimental Medicine
关键词[WOS]INDUCED CYTIDINE DEAMINASE ; RHEUMATOID-ARTHRITIS ; MICRORNA-155 ; RNA ; CAS9 ; REGULATOR ; MIR-155 ; PATHWAY ; GENE
英文摘要

MicroRNA 155 (miR-155) is a key proinflammatory regulator in clinical and experimental rheumatoid arthritis (RA). Here we generated a miR-155 genome knockout (GKO) RAW264.7 macrophage cell line using the clustered regulatory interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein 9 (CAS9) technology. While upregulating the Src homology-2 domain-containing inositol 5-phosphatase 1 (SHIP1), the miR-155 GKO line is severely impaired in producing proinflammatory cytokines but slightly increased in osteoclastogenesis upon treatment with receptor activator of nuclear factor-kappa B ligand (RANKL). Taken together, our results suggest that genome editing of miR-155 holds the potential as a therapeutic strategy in RA.

语种英语
所属项目编号81273697
资助者National Natural Science Foundation of China ; National Natural Science Foundation of China
WOS记录号WOS:000366410100001
Citation statistics
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/67643
Collection北京大学第二临床医学院
作者单位1.Beijing Univ Chinese Med, Affiliated Hosp 3, Dept Med Serv, Beijing 100029, Peoples R China
2.Peking Univ, Peoples Hosp, Clin Immunol Ctr, Dept Rheumatol & Immunol, Beijing 100044, Peoples R China
3.Beijing Univ Chinese Med, Sch Chinese Med, Dept Pharmacol, Beijing 100102, Peoples R China
4.Beijing Univ Chinese Med, Dongfang Hosp, Dept Rheumatol, Beijing 100078, Peoples R China
5.Peking Univ, Hosp 3, Dept Rheumatol & Immunol, Beijing 100191, Peoples R China
Recommended Citation
GB/T 7714
Jing, Weixia,Zhang, Xuewu,Sun, Wenyan,et al. CRISPR/CAS9-Mediated Genome Editing of miRNA-155 Inhibits Proinflammatory Cytokine Production by RAW264.7 Cells[J]. BIOMED RESEARCH INTERNATIONAL,2015.
APA Jing, Weixia,Zhang, Xuewu,Sun, Wenyan,Hou, Xiujuan,Yao, Zhongqiang,&Zhu, Yuelan.(2015).CRISPR/CAS9-Mediated Genome Editing of miRNA-155 Inhibits Proinflammatory Cytokine Production by RAW264.7 Cells.BIOMED RESEARCH INTERNATIONAL.
MLA Jing, Weixia,et al."CRISPR/CAS9-Mediated Genome Editing of miRNA-155 Inhibits Proinflammatory Cytokine Production by RAW264.7 Cells".BIOMED RESEARCH INTERNATIONAL (2015).
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Jing, Weixia]'s Articles
[Zhang, Xuewu]'s Articles
[Sun, Wenyan]'s Articles
百度学术
百度学术Similar articles in
[Jing, Weixia]'s Articles
[Zhang, Xuewu]'s Articles
[Sun, Wenyan]'s Articles
必应学术
必应学术Similar articles in
[Jing, Weixia]'s Articles
[Zhang, Xuewu]'s Articles
[Sun, Wenyan]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.